The increasing adoption of third party quality controls presents opportunities

DublinAnd the October 12 2022 /PRNewswire/ – file Molecular quality controls market share, size, trends by product, by technology, by application, by end use, by region, and sector forecast, 2022 – 2030 Report added to Show.

Research and Markets logo

Research and Markets logo

The global molecular quality control market is expected to reach $294.31 million USD by 2030.

Trends in the industry are driven by many variables, including the steadily increasing number of accredited clinical laboratories. Clinical laboratory tests helped not only diagnose the disease but also monitor the effectiveness of the treatment. Today, clinical laboratories around the world compete for national and international accreditation, largely to ensure more reliable and superior laboratory services. Diagnostic laboratories perform more complex testing, are subject to higher standards of regulatory compliance, and are subject to increasing levels of regulatory scrutiny.

For example, in April 2021Based on the results of on-site screening, the College of American Pathologists accredited the Clinical Laboratory of the Institute for Advanced Genomics at the University of California, Berkeley. In the coming years, there may be an increase in demand for control solutions as a result of urgent demand for intensive monitoring of any anomalies in diagnostic goods.

The primary factors driving the growth of this industry are the increasing use of third party regulatory standards, the desire to support external quality measurement, the development of government funding for genomics developments, the demand for personalized medicines, the low cost of sequencing procedures, and the increasing incidence of infectious diseases, cancers and genetic diseases.

Moreover, in July 2021, to compete in the multiplexed molecular diagnostics industry, partnered Seegene, a critical participant, and Bio-Rad Laboratories. The collaboration aims to find diagnostic solutions for infectious diseases. In addition, subject to FDA approval and further clinical research, Seegene will offer diagnostic tests for use in the Bio-CFX96 Rad’s Dx Real-Time PCR System for the US market.

As the burden of various diseases increases globally, more laboratory tests are being done. Public and commercial laboratories are being opened to meet this need. To perform diagnostic tests, clinical laboratories must obtain accreditation from regulatory organizations such as the International Organization for Standardization (ISO) and other standards of the same type in the majority of countries. Competent authorities analyze laboratory competence and quality system during the accreditation procedure using pre-defined criteria.

Highlights of the Molecular Quality Controls market report:

  • The genetic testing model segment is expected to grow at a significant CAGR during the forecast period. Genetic diseases are identified using these techniques because they facilitate interpretation of results. A full or partial second copy of chromosome 21 develops from faulty cell division, the genetic disease known as Down syndrome. In addition, the use of genetic testing for hereditary breast cancer is expanding as awareness of breast cancer increases.

  • Infectious disease diagnostics captured a large share of global revenue share which has accelerated by rising along with infectious disease treatment.

  • The North America region is expected to grow at a profitable compound annual growth rate (CAGR) during the projection period and has emerged as the leading regional share. Due to the presence of important competitors in the market and the increasing number of new control panels launched by leading companies, North Amarica It is expected to expand.

market dynamics

Drivers and opportunities

limitations and challenges

Market segmentation

Molecular Quality Controls, Product Outlook (Revenue – Million USD, 2018 – 2030)

  • does not depend on

  • specific instrument

Molecular Quality Controls, Technology Outlook (Revenue – Million USD, 2018 – 2030)

  • PCR

  • DNA sequencing and NGS

  • Other techniques

Molecular Quality Controls, Application Forecast (Revenue – Million USD, 2018 – 2030)

Molecular Quality Controls, End Use Forecast (Revenue – Million USD, 2018 – 2030)

Molecular Quality Controls, Regional Outlook (Revenue – Million USD, 2018 – 2030)

  • North Amarica

  • we

  • Canada

  • Europe

  • Germany

  • United kingdom

  • France

  • Italia

  • Spain

  • Russia

  • Holland

  • Asia Pacific

  • China

  • India

  • Japan

  • South Korea

  • Indonesia

  • Malaysia

  • Latin america

  • Argentina

  • Brazil

  • Mexico

  • The Middle East & Africa

  • The United Arab Emirates

  • Kingdom Saudi Arabia

  • Israel

  • South Africa

Main topics covered:

1 Introduction

2. Executive Summary

3. Research Methodology

4. Global Molecular Quality Controls Market Insights

5. Global Molecular System Quality Control Market, by Product

6. Global Molecular Quality Controls Market, by Technology

7. Global Molecular System Quality Control Market, by Application

8. Global Molecular System Quality Control Market, by end use

9. Global Molecular Quality Control Market by Geography

10. Competitive landscape

11. Company Profiles

mentioned companies

For more information about this report visit

Media contact:

Research and Markets
Laura Wooddirector, mentor

For EST office hours, call +1-917-300-0470
For US/Canada, call toll free +1-800-526-8630
For GMT office hours, call +353-1-416-8900

US Fax: 646-607-1907
Fax (outside the US): +353-1-481-1716




View original content:

SOURCE Research & Markets

Leave a Comment